Summary & Overview
HCPCS Q4388: Neothelium per Square Centimeter, Add-On
HCPCS Level II code Q4388 denotes a per-square-centimeter add-on billing code for Neothelium 4l, a biologic product applied in conjunction with a primary procedure. As an add-on supply code, it is intended to be reported separately in addition to the primary service when a clinician or facility uses this specific product measured by surface area. Nationally, granular reporting of product-based add-on codes matters for accurate facility reimbursement, cost tracking of biologic grafts, and compliance with payer billing policies.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical and billing context, typical sites of service, and the role of add-on product codes in claims. The publication summarizes common modifiers associated with product billing and outlines which elements are available and which are not. It also highlights where to look for payer-specific coverage rules and billing guidelines.
This analysis equips billing managers, revenue cycle staff, and clinicians with the essential facts needed to identify when Q4388 applies, what it represents on a claim, and which payers to consult for policy details. Data not available in the input is noted where relevant.
Billing Code Overview
HCPCS Level II code Q4388 describes Neothelium 4l, per square centimeter (add-on, list separately in addition to primary procedure). This code represents an add-on biologic product measured and billed per square centimeter, intended to be reported in addition to a primary surgical or therapeutic procedure that applies the product.
Service type: Biologic graft/dermal substitute product, itemized per sq cm
Typical site of service: Hospital operating room, ambulatory surgery center, or procedural clinic where operative or wound-repair procedures are performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult undergoing surgical removal of a benign or malignant skin lesion or soft-tissue defect where a tissue-engineered neothelial graft product is applied to the wound bed. The procedure is an add-on product billed per square centimeter (Q4388 for Neothelium 4 L, per square centimeter). The surgical workflow usually includes preoperative evaluation by a dermatologist, plastic surgeon, or general surgeon; excision or debridement of the lesion under local or regional anesthesia; hemostasis and measurement of the wound dimensions; application and fixation of the neothelial graft product; and standard postoperative dressing and wound care. The patient may have comorbidities such as diabetes or peripheral vascular disease that affect wound healing, requiring extended monitoring. Typical sites of service include hospital outpatient departments, ambulatory surgical centers, and physician offices where minor procedures are performed. Documentation should include wound measurements (cm2), indication for grafting, product lot number, quantity used, and operative or procedure note linking the graft application to the primary surgical procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no special circumstances or modifiers apply to the add-on product billing. |